Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.86 USD | +1.74% | +8.83% | -13.76% |
Business Summary
Number of employees: 1,453
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Tumor Treating Fields
100.0
%
| 538 | 100.0 % | 509 | 100.0 % | -5.30% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
68.7
%
| 407 | 75.7 % | 350 | 68.7 % | -14.05% |
Germany
11.8
%
| 46 | 8.6 % | 60 | 11.8 % | +30.55% |
Others
8.7
%
| 0 | 0.0 % | 44 | 8.7 % | - |
Japan
6.2
%
| 33 | 6.1 % | 32 | 6.2 % | -3.40% |
Greater China
4.6
%
| 21 | 4.0 % | 23 | 4.6 % | +8.87% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Asaf Danziger
CEO | Chief Executive Officer | 56 | 01/02/01 |
Ashley Cordova
DFI | Director of Finance/CFO | 45 | 01/14/01 |
Moshe Giladi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Nicolas Leupin
CTO | Chief Tech/Sci/R&D Officer | 50 | 04/01 |
Chief Operating Officer | 66 | 05/12/05 | |
Ingrid Goldberg
IRC | Investor Relations Contact | - | 01/21/01 |
Barak Ben Arye
LAW | General Counsel | 48 | 01/18/01 |
Corporate Officer/Principal | - | - | |
Uri Weinberg
PRN | Corporate Officer/Principal | 46 | 01/08/01 |
Michael Puri
HRO | Human Resources Officer | 55 | 01/23/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Doyle
CHM | Chairman | 61 | 01/04/01 |
Kin Yip Leung
BRD | Director/Board Member | 62 | 05/11/05 |
David Hung
BRD | Director/Board Member | 66 | 31/18/31 |
Timothy Scannell
BRD | Director/Board Member | 60 | 05/21/05 |
Jeryl Hilleman
BRD | Director/Board Member | 66 | 25/18/25 |
Tony Vernon
BRD | Director/Board Member | 68 | 01/06/01 |
Asaf Danziger
CEO | Chief Executive Officer | 56 | 01/02/01 |
Martin Madden
BRD | Director/Board Member | 64 | 10/17/10 |
Kristin Stafford
BRD | Director/Board Member | 42 | 28/23/28 |
Allyson Ocean
BRD | Director/Board Member | 52 | 23/23/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 107,606,309 | 97,642,935 ( 90.74 %) | 0 | 90.74 % |
Company contact information
NovoCure Ltd.
No. 4 The Forum Grenville Street
JE2 4UF, St. Helier
+44 15 3475 6700
http://www.novocure.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.76% | 1.36B | |
+73.30% | 12.38B | |
-19.52% | 7.92B | |
+15.74% | 7.2B | |
+6.78% | 5.84B | |
+7.49% | 5.07B | |
+23.97% | 4.53B | |
-21.67% | 3.88B | |
-40.53% | 2.23B | |
+1.24% | 2.02B |
- Stock Market
- Equities
- NVCR Stock
- Company NovoCure Limited